By: SUSAN BIRK, Clinical Psychiatry News Digital Network
Major Finding: Eating baked or broiled fish on a weekly basis improved brain health and significantly reduced the risk of mild cognitive impairment and Alzheimer’s disease.
Data Source: A 20-year longitudinal study of older adults.
Disclosures: Dr. Raji had no disclosures related to this study.
CHICAGO – Consumption of baked or broiled fish on a weekly basis improved brain health and significantly reduced the risk of mild cognitive impairment and Alzheimer’s disease in a 20-year longitudinal study of older adults presented at the annual meeting of the Radiological Society of North America.
Fish consumption improved brain volume in the frontal lobes, temporal lobes (including the hippocampus) and posterior cingulate gyrus, as shown on high-resolution, three-dimensional volumetric magnetic resonance imaging (MRI). "That’s important because these are areas of the brain that are responsible for memory and learning and are severely affected by Alzheimer’s disease," reported Dr. Cyrus A. Raji of the University of Pittsburgh.
|
The study findings indicate a large reduction in the risk for developing Alzheimer's disease or mild cognitive impairment as a result of eating baked or broiled fish.
|
Dr. Raji and his colleagues analyzed data collected at three time points from the ongoing Cardiovascular Health Study-Cognition Study. In 1989-1990, 260 subjects (mean age 71 years) completed standardized diet questionnaires. In 1998-1999, these individuals (mean age 78 years) underwent volumetric MRI.
An analysis of clinical conversion to mild cognitive impairment (MCI) or Alzheimer’s disease (AD) in 2002 among study participants (mean age 82 years) found that individuals with larger brain volumes as a result of weekly baked or broiled fish consumption had a greatly reduced incidence of MCI or AD, compared with individuals who did not eat fish regularly.
Clinical conversion rates to MCI or AD were 30.8% for non–fish eaters, compared with 8% for individuals whose brains benefited partially from fish consumption (as shown on volumetric MRI), and 3.2% for individuals whose brains benefited fully from fish consumption.
These findings indicate "a large reduction in the risk for developing AD or MCI as a result of consuming baked or broiled fish," Dr. Raji said
The benefits of regular fish intake persisted even after accounting for such potential confounding variables as age, gender, head size, and cerebrovascular disease.
Study participants who were not fish eaters and who showed atrophy in the hippocampus – the region most frequently affected by AD – had a 47% incidence of MCI or AD, compared with only 28% of fish eaters with larger hippocampal volumes, he reported.
In addition, mean scores on cognitive tests of working memory were significantly higher (P less than .05) in individuals who ate fish weekly compared with those who did not. The improvement remained even after accounting for potential confounders such as age, gender, and education.
The researchers also looked at cognitive test scores and brain volumes and found a relationship between larger frontal lobe volumes in fish eaters and higher working memory test scores. "This makes a lot of sense, because the frontal lobes are responsible for working memory function," Dr. Raji said.
The reduced risk of MCI and AD among fish eaters in this study probably stems from the protective benefits of omega-3 fatty acids, he noted. Omega-3 fatty acids are believed to increase blood flow to the brain, act as antioxidants and anti-inflammatories, and prevent the accumulation of the amyloid plaques characteristic of AD. Consumption of fried fish, which is high in cholesterol and low in omega-3 fatty acids, did not confer any benefits.
> more Dementia and Alzheimer's Disease articles
Interested in being notified of new Dementia and Alzheimer's Disease news?
Click here to view our Dementia and Alzheimer's Disease RSS Feed.
| May 24 - 27 Chicago, IL | Association for Psychological Science (APS): Annual Convention |
| May 29 - Jun 1 Phoenix, AZ | National Institute of Mental Health (NIMH): New Clinical Drug Evaluation Unit (NCDEU) |
| Jun 3 - 7 Stockholm, | Collegium Internationale Neuro-Psychopharmacologicum (CINP): World Congress |
| Jun 5 - 10 Kona, HI | International Behavioral Neuroscience Society (IBNS): Annual Meeting |
| Jun 12 - 17 Chicago, IL | American Psychoanalytic Association (APsaA): 101st Annual Meeting |
| Jun 18 - 26 Rapid City, SD | Reclaiming Youth International: 19th Annual Black Hills Seminars |
| Jun 23 - 27 San Francisco, CA | Research Society on Alcoholism (RSA): Annual Scientific Conference |
| Jul 10 - 13 Liverpool, | Royal College of Psychiatrists: Annual Meeting |
| Jul 21 - 28 Dpart Venice, | Primary Care: Mental Health Issues with a Focus on Drugs and Behavior |
| Jul 21 - 25 Paris, | International Association for Child & Adolescent Psych & Allied Professions (IACAPAP): World Congress |